Brief: Decibel Therapeutics Inc Says Elisabeth Leiderman Notified Co Of Her Intent To Resign
13/09/2022 13:15
Sept 13 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS INC - ELISABETH LEIDERMAN, M.D., CFO
NOTIFIED CO OF HER INTENT TO RESIGN, EFFECTIVE OCTOBER 7, 2022
* DECIBEL THERAPEUTICS INC - ON SEP 10, BOARD APPOINTED
JAMES
MURPHY AS INTERIM CFO OF THE COMPANY, EFFECTIVE AS OF OCTOBER 7,
2022
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary